Advances in cancer and chronic inflammatory diseases have led to better treatment options for patients.
These new agents have also led to drug hypersensitivity reactions. Desensitization has become important when there is no alternative therapy available or they are inferior or toxic. There are steps involved in evaluating these patients, factors to consider when deciding to desensitize and certain protocols that need to be followed to produce the best outcome.
Each potential agent can trigger a potential reaction. There are certain protocols available for medications, but with many new and distinct agents, there may not be any literature and it is necessary for your physician to come up with a desensitization program.